Nalaganje...
Long term response to erlotinib in a patient with recurrent vulvar carcinoma: Case report and review of literature()
► We report a case of recurrent vulvar carcinoma with a good response to erlotinib. ► Treatment was well tolerated with no serious side effects. ► Further evaluation of this new therapeutic approach may be warranted.
Shranjeno v:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3861161/ https://ncbi.nlm.nih.gov/pubmed/24371640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gynor.2012.07.002 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|